[{"bbox": [114, 95, 1704, 1105], "category": "Table", "text": "<table><thead><tr><td>Results</td><td>Results Chain: Main expected results (max. 10)</td><td>Indicators: (at least one indicator per expected result)</td><td>Baselines (values and years)</td><td>Targets (values and years)</td><td>Sources of data</td><td>Assumptions</td></tr></thead><tbody><tr><td>Outcome 2 / Specific Objective 2</td><td>To reinforce the National Regulatory Agency (NRA), CECMED, in its regulatory role and in monitoring the safety and efficacy of biotechnological products, according to international standards</td><td>2.1. Status of WHO certification of the National Regulatory Agency (NRA)<br>2.2. Average time needed for screening a biotechnological or a pharmaceutical product, disaggregated by product groups<br>2.3. Status of public communication by the NRA<br>2.4. Number of joint projects with European Agencies / Regulators<br>2.5. Status of digitalisation of internal business processes of NRA</td><td>2.1. None by 2022<br>2.2. TBD in the inception period<br>2.3. None by 2022<br>2.4. TBD<br>2.5. Not digitalised</td><td>2.1. Performance and NRA found compatible with the standards of WHO Global Assessment Tool for Regulatory Authorities by &lt;5 years &gt;<br>2.2. TBD in the inception period<br>2.3. Regular reports issued in &lt;2 years&gt; and communication organised in &lt;2 years&gt;<br>2.4. TBD in the inception period<br>2.5. Fully digitalised</td><td>2.1. WHO certification report<br>2.2. Internal NRA reports on specific products<br>2.3. Reports and communications issued<br>2.4. Projects and their approval by the parties<br>2.5. The NRA IT department report</td><td>CECMED further receives a dedicated support by the government to develop its systems and capacities, and has an institutional development plan<br>WHO and EU Agencies / Regulators support CECMED to plan and organise the certification and launch projects</td></tr><tr><td>Outcome 3 / Specific Objective 3</td><td>To create new opportunities for biotechnological scientific cooperation between EU and Cuba (international scientific project management, public procurement competences, etc.)</td><td>3.1. Number of graduates from the Havana University who graduate from programme on project management<br>3.2. Number of professionals using ICH Q5 guideline and technical facilities created by the Action<br>3.3. Number of publications in peer reviewed international scientific periodicals</td><td>3.1. 0 by 2022<br>3.2. 0 by 2022<br>3.3. 0 by 2022<br>3.4. TBD in the inception period</td><td>3.1. TBD in the inception period<br>3.2. TBD in the inception period<br>3.3. TBD in the inception period<br>3.4. TBD in the inception period</td><td>3.1. Havana University graduates' records<br>3.2. NRA's observations, data from scientific observatory<br>3.3. Publications in the periodicals<br>3.4. Yearly communications</td><td>The government, investors and biopharmaceutical industry invests into the further maintenance and development of the established systems, infrastructure and practices of scientific-research development in the country</td></tr></tbody></table>"}, {"bbox": [1525, 1149, 1644, 1173], "category": "Page-footer", "text": "Page 14 of 24"}]